SKELLY WILLIAM G

Director at ACURA PHARMACEUTICALS, INC · on record since Feb 14, 2006

Insider trading activity of SKELLY WILLIAM G

Transactions on record: 89; since Aug 13, 2004

Open-market buys: 1; $10K

Open-market sells: 35; $352.1K

Companies traded: 1; last filing Jan 15, 2026

Figures computed from official regulatory filings — methodology.

Companies where SKELLY WILLIAM G has traded

ACURA PHARMACEUTICALS, INC89 tx · $413.4K · Jan 15, 2026

Track record of SKELLY WILLIAM G

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of SKELLY WILLIAM G

Co-insiders of SKELLY WILLIAM G

Abuse Deterrent Pharma, LLCACURA PHARMACEUTICALS, INC
Azad DavidACURA PHARMACEUTICALS, INC
Boehm GarthACURA PHARMACEUTICALS, INC
Brzeczko Albert WACURA PHARMACEUTICALS, INC
CARE CAPITAL II LLCACURA PHARMACEUTICALS, INC
CARE CAPITAL INVESTMENTS II LPACURA PHARMACEUTICALS, INC
Care Capital Offshore Investments II LPACURA PHARMACEUTICALS, INC

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
ACURA PHARMACEUTICALS, INC	Jan 15, 2026	Exercise	50,000	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 15, 2026	ExerciseD	-50,000	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 15, 2026	AwardD	-50,000	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 24, 2025	ExerciseD	-50,000	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 24, 2025	AwardD	-50,000	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 24, 2025	Exercise	50,000	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 2, 2024	Exercise	50,000	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 2, 2024	AwardD	-50,000	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 2, 2024	ExerciseD	-50,000	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 5, 2023	Exercise	66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 5, 2023	ExerciseD	-66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 5, 2023	AwardD	-50,000	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 5, 2022	Exercise	66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 5, 2022	AwardD	-66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 5, 2022	ExerciseD	-66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	May 28, 2021	AwardD	66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 6, 2021	Exercise	54,790	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 6, 2021	ExerciseD	-54,790	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 6, 2020	Exercise	83,333	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 6, 2020	AwardD	54,790	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 6, 2020	ExerciseD	-83,333	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 4, 2019	AwardD	83,333	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 4, 2019	Exercise	66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 4, 2019	ExerciseD	-66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 3, 2018	Exercise	59,523	—	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
ACURA PHARMACEUTICALS, INC	Jan 15, 2026	Exercise	50,000	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 15, 2026	ExerciseD	-50,000	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 15, 2026	AwardD	-50,000	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 24, 2025	ExerciseD	-50,000	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 24, 2025	AwardD	-50,000	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 24, 2025	Exercise	50,000	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 2, 2024	Exercise	50,000	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 2, 2024	AwardD	-50,000	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 2, 2024	ExerciseD	-50,000	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 5, 2023	Exercise	66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 5, 2023	ExerciseD	-66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 5, 2023	AwardD	-50,000	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 5, 2022	Exercise	66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 5, 2022	AwardD	-66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 5, 2022	ExerciseD	-66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	May 28, 2021	AwardD	66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 6, 2021	Exercise	54,790	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 6, 2021	ExerciseD	-54,790	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 6, 2020	Exercise	83,333	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 6, 2020	AwardD	54,790	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 6, 2020	ExerciseD	-83,333	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 4, 2019	AwardD	83,333	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 4, 2019	Exercise	66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 4, 2019	ExerciseD	-66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 3, 2018	Exercise	59,523	—	—	SEC